RTW Investments’s Immunovant IMVT Stock Holding History

RTW Investments’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$122M	Hold	3,177,849	–	–	1.05%	32
2026 Q1	$78.9M	Sell	3,177,849 -1	-0%	-$26	0.79%	35
2025 Q4	$80.8M	Buy	+3,177,850	New	+$70.9M	0.81%	36
2025 Q1	–	Sell	-530,614	Closed	-$13.1M	–	75
2024 Q4	$13.1M	Buy	+530,614	New	+$15.1M	0.2%	53
2021 Q2	–	Sell	-6,356,743	Closed	-$102M	–	117
2021 Q1	$102M	Sell	6,356,743 -1,235,510	-16%	-$32.6M	1.59%	20
2020 Q4	$351M	Buy	7,592,253 +81,841	+1%	+$3.78M	5.88%	2
2020 Q3	$264M	Buy	7,510,412 +1,793,230	+31%	+$53.9M	6.36%	2
2020 Q2	$139M	Buy	5,717,182 +1,291,076	+29%	+$27.7M	3.92%	6
2020 Q1	$65.9M	Hold	4,426,106	–	–	2.84%	11
2019 Q4	$66M	Buy	+4,426,106	New	+$49.6M	2.49%	12

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RTW Investments's IMVT Position: Q2 2026 in Review

RTW Investments held its Immunovant (IMVT) position steady in Q2 2026 at 3,177,849 shares worth $122M. The position accounts for 1.05% of the portfolio, ranked #32.

RTW Investments first reported a position in IMVT in Q4 2019 and has held it in 10 quarters since. The position peaked at $351M in Q4 2020. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

RTW Investments held 3,177,849 shares of Immunovant worth $122M as of Q2 2026.
RTW Investments left its Immunovant share count unchanged in Q2 2026.
Immunovant made up 1.05% of RTW Investments's portfolio in Q2 2026, its #32 holding.
RTW Investments first reported a position in Immunovant in Q4 2019 and has held it in 10 quarters since.
RTW Investments's Immunovant position peaked at $351M in Q4 2020.
226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.